237 related articles for article (PubMed ID: 34745066)
1. The Diverse Applications of Recombinant BCG-Based Vaccines to Target Infectious Diseases Other Than Tuberculosis: An Overview.
Mouhoub E; Domenech P; Ndao M; Reed MB
Front Microbiol; 2021; 12():757858. PubMed ID: 34745066
[TBL] [Abstract][Full Text] [Related]
2. Applications of bacillus Calmette-Guerin and recombinant bacillus Calmette-Guerin in vaccine development and tumor immunotherapy.
Zheng YQ; Naguib YW; Dong Y; Shi YC; Bou S; Cui Z
Expert Rev Vaccines; 2015; 14(9):1255-75. PubMed ID: 26268434
[TBL] [Abstract][Full Text] [Related]
3.
Jia Q; Masleša-Galić S; Nava S; Horwitz MA
mBio; 2022 Jun; 13(3):e0068722. PubMed ID: 35642945
[TBL] [Abstract][Full Text] [Related]
4. Cyclic di-AMP as endogenous adjuvant enhanced BCG-induced trained immunity and protection against
Ning H; Kang J; Lu Y; Liang X; Zhou J; Ren R; Zhou S; Zhao Y; Xie Y; Bai L; Zhang L; Kang Y; Gao X; Xu M; Ma Y; Zhang F; Bai Y
Front Immunol; 2022; 13():943667. PubMed ID: 36081510
[TBL] [Abstract][Full Text] [Related]
5. A live attenuated BCG vaccine overexpressing multistage antigens Ag85B and HspX provides superior protection against Mycobacterium tuberculosis infection.
Yuan X; Teng X; Jing Y; Ma J; Tian M; Yu Q; Zhou L; Wang R; Wang W; Li L; Fan X
Appl Microbiol Biotechnol; 2015 Dec; 99(24):10587-95. PubMed ID: 26363555
[TBL] [Abstract][Full Text] [Related]
6. Immunogenic potential of latency associated antigens against Mycobacterium tuberculosis.
Singh S; Saraav I; Sharma S
Vaccine; 2014 Feb; 32(6):712-6. PubMed ID: 24300592
[TBL] [Abstract][Full Text] [Related]
7. Recombinant BCG With Bacterial Signaling Molecule Cyclic di-AMP as Endogenous Adjuvant Induces Elevated Immune Responses After
Ning H; Wang L; Zhou J; Lu Y; Kang J; Ding T; Shen L; Xu Z; Bai Y
Front Immunol; 2019; 10():1519. PubMed ID: 31333655
[TBL] [Abstract][Full Text] [Related]
8. Immunogenicity and protective efficacy conferred by a novel recombinant Mycobacterium bovis bacillus Calmette-Guérin strain expressing interleukin-12p70 of human cytokine and Ag85A of Mycobacterium tuberculosis fusion protein.
Deng YH; He HY; Zhang FJ
Scand J Immunol; 2013 Dec; 78(6):497-506. PubMed ID: 24283772
[TBL] [Abstract][Full Text] [Related]
9. The Induction of Antigen 85B-Specific CD8
Komine-Aizawa S; Mizuno S; Kawano A; Hayakawa S; Matsuo K; Honda M
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674484
[No Abstract] [Full Text] [Related]
10. Manipulation of BCG vaccine: a double-edged sword.
Singh VK; Srivastava R; Srivastava BS
Eur J Clin Microbiol Infect Dis; 2016 Apr; 35(4):535-43. PubMed ID: 26810060
[TBL] [Abstract][Full Text] [Related]
11. Enhanced and durable protective immune responses induced by a cocktail of recombinant BCG strains expressing antigens of multistage of Mycobacterium tuberculosis.
Liang J; Teng X; Yuan X; Zhang Y; Shi C; Yue T; Zhou L; Li J; Fan X
Mol Immunol; 2015 Aug; 66(2):392-401. PubMed ID: 25974877
[TBL] [Abstract][Full Text] [Related]
12. Comparison of BCG prime-DNA booster and rBCG regimens for protection against tuberculosis.
Tan K; Liang J; Teng X; Wang X; Zhang J; Yuan X; Fan X
Hum Vaccin Immunother; 2014; 10(2):391-8. PubMed ID: 24192709
[TBL] [Abstract][Full Text] [Related]
13. Novel recombinant BCG coexpressing Ag85B, ESAT-6 and Rv2608 elicits significantly enhanced cellular immune and antibody responses in C57BL/6 mice.
Lu Y; Xu Y; Yang E; Wang C; Wang H; Shen H
Scand J Immunol; 2012 Sep; 76(3):271-7. PubMed ID: 22671973
[TBL] [Abstract][Full Text] [Related]
14. Thirty years of recombinant BCG: new trends for a centenary vaccine.
Marques-Neto LM; Piwowarska Z; Kanno AI; Moraes L; Trentini MM; Rodriguez D; Silva JLSC; Leite LCC
Expert Rev Vaccines; 2021 Aug; 20(8):1001-1011. PubMed ID: 34224293
[No Abstract] [Full Text] [Related]
15. SOCS1 Antagonist-Expressing Recombinant Bacillus Calmette-Guérin Enhances Antituberculosis Protection in a Mouse Model.
Mizuno S; Soma S; Inada H; Kanuma T; Matsuo K; Yasutomi Y
J Immunol; 2019 Jul; 203(1):188-197. PubMed ID: 31101668
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of protective efficacy conferred by a recombinant Mycobacterium bovis BCG expressing a fusion protein of Ag85A-ESAT-6.
Deng YH; He HY; Zhang BS
J Microbiol Immunol Infect; 2014 Feb; 47(1):48-56. PubMed ID: 23357605
[TBL] [Abstract][Full Text] [Related]
17. Expression and immunogenicity of recombinant Mycobacterium bovis Bacillus Calmette-Guérin strains secreting the antigen ESAT-6 from Mycobacterium tuberculosis in mice.
Wang LM; Shi CH; Fan XL; Xue Y; Bai YL; Xu ZK
Chin Med J (Engl); 2007 Jul; 120(14):1220-5. PubMed ID: 17697571
[TBL] [Abstract][Full Text] [Related]
18. Is interferon-gamma the right marker for bacille Calmette-Guérin-induced immune protection? The missing link in our understanding of tuberculosis immunology.
Abebe F
Clin Exp Immunol; 2012 Sep; 169(3):213-9. PubMed ID: 22861360
[TBL] [Abstract][Full Text] [Related]
19. Mycobacterium bovis Bacille Calmette-Guérin as a Vaccine Vector for Global Infectious Disease Control.
Matsuo K; Yasutomi Y
Tuberc Res Treat; 2011; 2011():574591. PubMed ID: 22567267
[TBL] [Abstract][Full Text] [Related]
20. A novel recombinant Mycobacterium bovis bacillus Calmette-Guerin strain expressing human granulocyte macrophage colony-stimulating factor and Mycobacterium tuberculosis early secretory antigenic target 6 complex augments Th1 immunity.
Yang X; Bao L; Deng Y
Acta Biochim Biophys Sin (Shanghai); 2011 Jul; 43(7):511-8. PubMed ID: 21676888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
